A genetic clue to mood: How CD38 and CD157 interact in depression
Recent research in Physiology & Behavior investigates the neuropharmacology of depression using a mouse model lacking the Bst1/Cd157 gene, which is linked to social deficits and depression-like states. The study found that the depression-like behaviors in these knock-out mice were significantly reduced when the animals were also deficient in the Cd38 gene. This suggests a complex, interactive role between these two related cell-surface enzymes in regulating mood and behavior, pointing to a potential shared signaling pathway relevant to affective disorders. The findings offer a new avenue for exploring targeted pharmacodynamics and receptor binding mechanisms in psychopharmacology.
Study Significance: For pharmacologists and neuroscientists, this work identifies CD38 and CD157 as potential novel targets for drug discovery in mood disorders. Understanding their interaction could inform the development of more precise agonists or antagonists, moving beyond traditional monoamine-based therapies. This research underscores the importance of genetic models in unraveling complex signal transduction pathways that govern efficacy and therapeutic window in next-generation neuropharmacology.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
